Endothelial dysfunction is known to occur due to decreases in NO bioavailability and increases in endothelin-1 (ET-1), angiotensin II, and oxidant levels, which contribute to an imbalance in endothelium-derived relaxing and constricting factors (36). This evidence concerns the gene EDN1 and endothelial dysfunction.